GES-11, a novel integron-associated GES variant in Acinetobacter baumannii

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 8, 2009, Pages 3579-3581

  Moubareck, Carole ^a   Brémont, Sylvie ^a   Conroy, Marie Christine ^b   Courvalin, Patrice ^a   Lambert, Thierry ^a  

^a INSTITUT PASTEUR   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AZTREONAM; BETA LACTAMASE; CARBAPENEM; CEFOTAXIME; CHLORAMPHENICOL; CLAVULANIC ACID; COLISTIN; COTRIMOXAZOLE; GES 11 ENZYME; GLYCYLCYCLINE DERIVATIVE; IMIPENEM; MEROPENEM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ACINETOBACTER BAUMANNII; AGAR GEL ELECTROPHORESIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENE STRUCTURE; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACINETOBACTER BAUMANNII; ANTI-BACTERIAL AGENTS; AZTREONAM; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; INTEGRONS; MICROBIAL SENSITIVITY TESTS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PLASMIDS;

EID: 67749122374     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00072-09     Document Type: Article

References (21)

1. Bergogne-Berezin, E., and K. J. Towner. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin. Microbiol. Rev. 9:148-165.
2. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
3. Comité de l'Antibiogramme de la Société Française de Microbiologie. 2009. Communiqué 2009. Société Française de Microbiologie, Paris, France. http: //www.sfm.asso.fr.
4. Correia, M., F. Boavida, F. Grosso, M. J. Salgado, L. M. Lito, J. M. Cristino, S. Mendo, and A. Duarte. 2003. Molecular characterization of a new class 3 integron in Klebsiella pneumoniae. Antimicrob. Agents Chemother. 47:2838-2843.
5. Depardieu, F., I. Podglajen, R. Leclercq, E. Collatz, and P. Courvalin. 2007. Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20:79-114.
6. Dubois, V., L. Poirel, C. Marie, C. Arpin, P. Nordmann, and C. Quentin. 2002. Molecular characterization of a novel class 1 integron containing bla(GES-1) and a fused product of aac3- Ib/aac6′-Ib′ gene cassettes in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 46:638-645.
7. Fournier, P. E., D. Vallenet, V. Barbe, S. Audic, H. Ogata, L. Poirel, H. Richet, C. Robert, S. Mangenot, C. Abergel, P. Nordmann, J. Weissenbach, D. Raoult, and J. M. Claverie. 2006. Comparative genomics of multidrug resistance in Acinetobacter baumannii. PLoS Genet. 2:762-772.
8. Garnier, F., N. Raked, A. Gassama, F. Denis, and M. C. Ploy. 2006. Genetic environment of quinolone resistance gene qnrB2 in a complex sul1-type integron in the newly described Salmonella enterica serovar Keurmassar. Antimicrob. Agents Chemother. 50:3200-3202.
9. Giamarellou, H., A. Antoniadou, and K. Kanellakopoulou. 2008. Acinetobacter baumannii: a universal threat to public health? Int. J. Antimicrob. Agents 32:106-119.
10. Guessennd, N., S. Bremont, V. Gbonon, A. Kacou-Ndouba, E. Ekaza, T. Lambert, M. Dosso, and P. Courvalin. 2008. Qnr-type quinolone resistance in extended-spectrum β-lactamase producing enterobacteria in Abidjan, Ivory Coast. Pathol. Biol. (Paris) 56:439-446.
11. Lambert, T., G. Gerbaud, and P. Courvalin. 1988. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3′-aminoglycoside phosphotransferase. Antimicrob. Agents Chemother. 32:15-19.
12. Mammeri, H., P. Nordmann, A. Berkani, and F. Eb. 2008. Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli. FEMS Microbiol. Lett. 282:238-240.
13. Maragakis, L. L., and T. M. Perl. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin. Infect. Dis. 46:1254-1263.
14. Poirel, L., L. Brinas, N. Fortineau, and P. Nordmann. 2005. Integron-encoded GES-type extended-spectrum β-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 49:3593-3597.
15. Poirel, L., I. Le Thomas, T. Naas, A. Karim, and P. Nordmann. 2000. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron In52 from Klebsiella pneumoniae. Antimicrob. Agents Chemother. 44:622-632.
16. Poirel, L., and P. Nordmann. 2006. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin. Microbiol. Infect. 12:826-836.
17. Poirel, L., G. F. Weldhagen, T. Naas, C. De Champs, M. G. Dove, and P. Nordmann. 2001. GES-2, a class A β-lactamase from Pseudomonas aeruginosa with increased hydrolysis of imipenem. Antimicrob. Agents Chemother. 45:2598-2603.
18. Queenan, A. M., and K. Bush. 2007. Carbapenemases: the versatile β-lactamases. Clin. Microbiol. Rev. 20:440-458.
19. Vourli, S., P. Giakkoupi, V. Miriagou, E. Tzelepi, A. C. Vatopoulos, and L. S. Tzouvelekis. 2004. Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol. Lett. 234:209-213.
20. Wachino, J., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, and Y. Arakawa. 2004. Molecular characterization of a cephamycin-hydrolyzing and inhibitor-resistant class A β-lactamase, GES-4, possessing a single G170S substitution in the Ω-loop. Antimicrob. Agents Chemother. 48:2905-2910.
21. Wachino, J., Y. Doi, K. Yamane, N. Shibata, T. Yagi, T. Kubota, H. Ito, and Y. Arakawa. 2004. Nosocomial spread of ceftazidime-resistant Klebsiella pneumoniae strains producing a novel class a β-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48: 1960-1967.